Vera Therapeutics

Vera's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases, including IgA nephropathy (IgAN), also known as Berger's disease and lupus nephritis.. Vera is also developing MAU868, a monoclonal antibody designed to neutralize infection with BK Virus, a polyomavirus that can have devastating consequences in certain settings such as kidney transplant.. The Senior Director will report to the Vice President of Commercial Strategy and will create and lead market access strategies and tactics that drive the successful commercialization of atacicept.. Create payer value proposition for atacicept's lead indication of IgA Nephropathy and refine it via feedback received from US payer advisory boards.. Bachelor's degree required, advanced degree in related field (e.g., MBA, MPH, MPA, or PharmD) preferred.

senior director

<p>Title: Senior Director, Market Access & Reimbursement</p>
<p>Location: Brisbane, California (or Remote)</p>
<h3>About Us</h3>
<p>Vera Therapeutics (Nasdaq: VERA), is a late-stage biotechnology company focused on developing treatments for serious immunological diseases. Vera's mission is to advance treatments that target the source of immunologic diseases in order to change the standard of care for patients. Vera's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases, including IgA nephropathy (IgAN), also known as Berger's disease and lupus nephritis. In addition, Vera is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful. Vera is also developing MAU868, a monoclonal antibody designed to neutralize infection with BK Virus, a polyomavirus that can have devastating consequences in certain settings such as kidney transplant. For more information please visit: www.veratx.com.</p>
<p>Our values are the cornerstone of our culture. Our values inspire us every day and guide everything we do-from how we hire great people, to advancing our mission together, to achieving our ultimate goal to improve medical treatment for patients suffering from immunological diseases.</p>
<h3>Position Summary</h3>
<p>We seek a Senior Director, Market Access & Reimbursement to join a fast-paced, entrepreneurial, and collaborative team. The Senior Director will report to the Vice President of Commercial Strategy and will create and lead market access strategies and tactics that drive the successful commercialization of atacicept. This is a high-impact role where success will require the individual to develop strong cross-functional relationships in a multicultural environment, and to provide commercial leadership within a rapidly evolving organization.</p>
<h3>Responsibilities</h3>
<ul>
<li>Create payer value proposition for atacicept's lead indication of IgA Nephropathy and refine it via feedback received from US payer advisory boards.</li>
<li>Develop and deliver pricing strategies required to maximize the pipeline of atacicept through its lifecycle.</li>
<li>Partner on labelling strategy with regulatory, clinical, and health outcomes to meet payer needs and deliver on broad and smooth market access goal for US patients.</li>
<li>Create evidence generation plan. Identify and create mitigation plans against potential risks associated with unplanned coverage restrictions, price erosion, or delays to access.</li>
<li>As atacicept approaches product launch, oversee creation and on-time delivery of value evidence resources to achieve price and US access goals, including value dossiers, budget impact models, formulary kits, and access marketing materials.</li>
<li>As atacicept approaches product launch, oversee development and execution of payer value messaging resources (branded & unbranded).</li>
<li>Update and evolve atacicept's US reimbursement strategy and provider-channel strategy over time as new data or market-events emerge.</li>
<li>As needed, generate global market access insights including European HTA assessments or global advisory feedback.</li>
<li>Support initial planning for trade and product distribution strategies.</li>
<li>Support initial planning for patient hub and patient support services including analysis of claims, billing, and co-pay assistance programs.</li>
<li>Manage plans, internal budgets, and contracts internally and with external agency partners.</li>
<li>Partner with legal, regulatory, and medical stakeholders to ensure compliant development and execution of initiatives.</li>
</ul>
<h3>Qualifications</h3>
<ul>
<li>Bachelor's degree required, advanced degree in related field (e.g., MBA, MPH, MPA, or PharmD) preferred.</li>
<li>10+ years pharmaceutical/biotech experience, with a minimum 5 years of market access experience including specific access experience launching new indications or new products.</li>
<li>Experience with global markets and payer environment, (e.g. HTAs, US payer coverage and reimbursement, pricing and contracting, specialty pharmacies, formulary management, health technology assessment and payment policy). Direct experience in payer negotiations desirable.</li>
<li>Strong negotiating skills and ability to develop relationships and appropriately influence all partners, ideally from local experience influencing and leading access and pricing negotiations in relevant geographic markets.</li>
<li>Ability to make clear business arguments and strategic recommendations leveraging both quantitative and qualitative evidence.</li>
<li>Excellent communication, negotiation, presentation, and influencing skills while addressing the needs of multiple stakeholders.</li>
<li>Ability to work on multiple projects simultaneously and effectively prioritize work with a sense of urgency. Ability to work in a rapidly changing environment.</li>
<li>Highly skilled in partnering with teams in cross-functional matrix environments including interfacing with key internal and external groups in different regions.</li>
</ul>
<p>Vera Therapeutics Inc. is an equal-opportunity employer.</p>
<p>Vera Therapeutics is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. The starting base pay range for this position is $275,000 per year. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate's geography, qualifications, skills, and experience.</p>
<p>At Vera, base pay is only one part of your total compensation package. The successful candidate will be eligible for an annual performance incentive bonus, new hire equity, and ongoing performance-based equity. Vera Therapeutics also offers various benefits offerings, including, but not limited to, medical, dental, and vision insurance, 401k match, flexible time off, and a number of paid holidays.</p>
<p>COVID-19 Policy</p>
<p>Vera's top priority is the health and safety of our employees, their families and the communities where they live and work. As part of our commitment to health and safety, we require all U.S. employees to be fully vaccinated against COVID-19. If your role at Vera requires you to work or otherwise be on Vera's premises, full or part-time, we require our employees to comply with Vera's mandatory COVID-19 vaccination policy (currently requiring full vaccination). Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, may request a reasonable accommodation with Human Resources. Your employment is also subject to ongoing compliance with the mandatory vaccination policy and all other Vera policies, as they may be modified from time to time, at the sole discretion of Vera.</p>
<p>Notice to Recruiters/Staffing Agencies</p>
<p>Recruiters and staffing agencies should not contact Vera Therapeutics through this page. All recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees.</p>
<p>We require that all recruiters and staffing agencies have a fully executed, formal written agreement on file.</p>
<p>Vera Therapeutics' receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Vera Therapeutics and such organization and will be considered unsolicited and Vera Therapeutics will not be responsible for related fees.</p>

START NEW SEARCH